1)Molecular targeted therapy分子靶向治疗
1.Molecular targeted therapy of digestive system neoplasms;消化系统肿瘤的分子靶向治疗
2.Intron 1 (CA)n dinucleotide repeat polymorphism and mutations of epidermal growth factor receptor and responsiveness of molecular targeted therapy in lung cancerEGFR第一内含子(CA)n双核苷酸重复多态性和基因突变与肺癌分子靶向治疗的反应
3.In the era of molecular targeted therapy,recent promising diagnostic and the.进入分子靶向治疗时代,医学科学界对颅内肿瘤的分子机制愈增了解,加上诊断和医疗技术的长足进步,肿瘤的综合治疗不断有新的内容充实,为颅内肿瘤患者的个体化治疗与康复带来希望的曙光。
英文短句/例句
1.Molecular targeted therapies:targeting receptor tyrosine kinases in the treatment of gastric cancer靶向于受体酪氨酸激酶的胃癌分子靶向治疗
2.The Surgical and Molecular Target Therapy of Gastrointestinal Stromal Tumor in Huashan Hospital胃肠道间质瘤的手术和分子靶向治疗
3.Observation of Therapeutic Effect about Targeted Therapy on Gastrointestinal Stromal Tumors胃肠道间质瘤分子靶向治疗效果观察
4.Progression of chemotherapy and molecular targeted treatment in soft tissue sarcoma软组织肉瘤化疗和分子靶向治疗的新进展
5.Treatment Based on Syndrome Differentiation and Molecular Targeted Therapy of Cancer论中医的辨证论治与肿瘤的分子靶向治疗
6.Development in chemotherapy and molecular targeted drugs of NSCLS非小细胞肺癌化疗及分子靶向治疗药物的研究进展
7.Lentivirus-mediated LI-cadherin RNAi Combined with rAd-p53 Molecular Targeted Therapies in Hepatocellular Carcinoma;基因干扰肝肠钙黏附蛋白联合p53分子靶向治疗肝癌的实验研究
8.Epidermal Growth Factor Receptor Gene Mutation and the Molecular Target Therapy of Late Period Non-small-cell Lung CancerEGFR基因突变与晚期非小细胞肺癌（NSCLC）的分子靶向治疗
9.Expression of EGFR,HER-2,VEGF in tumour tissues and their directive significance for the molecular targeting therapy of colorectal carcinoma大肠癌EGFR、HER-2、VEGF表达特点及其对分子靶向治疗的指导意义
10.THE INFLUENCE OF MOLECULAR TARGETED THERAPY OF CANCERBASED ON THE HUMANIZED MONOCLONAL ANTIBODY人源化单克隆抗体用于肿瘤分子靶向治疗的研究进展
11.Sunitinib as a molecular targeting agent in renal cell carcinoma分子靶向药物舒尼替尼治疗肾细胞癌
12.Molecular Based Combination of Endocrine and Target Therapy in Breast Cancer乳腺癌内分泌联合靶向治疗的分子基础
13.Experimental Study of Molecularly Targeted Therapy for Glioma in Vitro;针对胶质瘤病因分子的靶向治疗实验研究
14.A Study of Pazopanib in Chinese Patients with Metastatic Renal Cell Carcinoma;分子靶向药物Pazopanib治疗转移性肾癌的临床研究
15.A Double Hit to Kill B Lymphoma Cells Targeted by mBAFF以mBAFF为靶向分子双重治疗B淋巴瘤的实验研究
16.Efficacy of Molecular Therapeutic Combination with Radiation in Head and Neck Cancer Cells分子靶向联合放射治疗头颈部鳞癌的实验研究
17.Immuno -target treatment with CD44V6 and cellular surface technology粘附分子CD44v6免疫靶向治疗与细胞表面工程技术
18.Experimental Study of Targeting Gene Therapy for Prostate Cancer Using Polyamidoamine Dendrimers as Nonviral Vector;应用树枝状高分子载体靶向基因治疗前列腺癌的实验研究
相关短句/例句
molecular target therapy分子靶向治疗
1.Molecular target therapy(MTT),using chemicals of low molecular weight,monoclonal antibodies,and/or polypeptides to interfere with specific signal pathways in cancer cells,causes inhibition of tumor progression.此后,肿瘤治疗徘徊不前,直到分子靶向治疗出现。
3)molecularly targeted therapy分子靶向治疗
1.Advances in molecularly targeted therapy of metastatic renal cell carcinoma;转移性肾细胞癌分子靶向治疗进展
2.The molecularly targeted therapy in some cancer has made dramatic progress in recent years,and inspring results have also achieved in clinical trials.近年来,分子靶向治疗对一些肿瘤已取得突破性进展,肝癌的分子靶向治疗也在临床试验中取得了令人鼓舞的结果。
3.Molecularly targeted therapy is a highlight of new pattern for cancer treatment, which has been a Research hot spot in recent years with its Specificity and Efficacy.分子靶向治疗是近年来肿瘤治疗的一个闪光点,凭着它的特异性和有效性,目前已成为国内外肿瘤治疗的研究热点。
4)Targeted molecular therapy分子靶向治疗
5)therapeutic molecule target分子治疗靶
6)combined molecular ta联合分子靶向治疗
延伸阅读
靶向给药分子式：CAS号：性质：靶制剂选择性地与靶细胞结合产生药理效应的过程。由于不同的给药途径药靶物制剂可以进入不同的位置，而产后不同的靶向性和作用特点。如脂质体制剂，可以静脉、腹腔、肌肉、皮下或淋巴结注射，也可以支气管给药或大脑内、脊椎给药。静脉给药时，脂质体在体内优先被富含网状内皮细胞的组织（肝脾）所摄取，并迅速被单核吞噬细胞吞噬和降解。主要包括脂质体给药系统、受体靶向及磁性药物。脂质体制剂是把药物包裹在双分子脂质膜中，此种磷脂膜与生物膜类似，成为药物的载体，它与细胞膜亲和力强，使癌细胞摄取增多，提高疗效，增加耐受性。受体靶向是利用脂质体的表面有共价键与抗肿瘤细胞表面抗原的单克隆抗体结合，使脂质体在肿瘤细胞内大量集中，提高抗肿瘤细胞的选择性。磁性药物是指药物与高磁性的硫酸铁结合，在给药后，体外使用强大的磁场，使肿瘤部位处于此种强大磁场之下，药物被选择性地集中在肿瘤细胞，提高治疗指数。
